Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings

Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form of autoinjector (pen-injector device) in outpatient facilities compared with its use in the form of a syringe in hospital settings for the treatment of severe asthma (SA).Material and methods. The cost minimi...

全面介紹

書目詳細資料

發表在:	Фармакоэкономика
Main Authors:	M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin
格式:	Article
語言:	俄语
出版:	IRBIS LLC 2022-07-01
主題:	severe asthma benralizumab eosinophilic asthma pharmacoeconomic analysis autoinjector pen-injector device
在線閱讀:	https://www.pharmacoeconomics.ru/jour/article/view/692